Showing results (1-10 of 1,026) with videos related to
Sort By:
Pageof 103
Current Opinion in Neurology|November 6, 2010
2010: neuro-oncology is moving!Roger Stupp, Michael WellerThe Lancet. Oncology|September 1, 2012
Epilepsy meets cancer: when, why, and what to do about it?Michael Weller, Roger Stupp, Wolfgang WickCurrent Opinion in Neurology|October 25, 2013
Malignant astrocytoma in elderly patients: where do we stand?Ghazaleh Tabatabai, Roger Stupp, Wolfgang Wick, et al.Cancer Journal (Sudbury, Mass.)|February 1, 2012
Individualized targeted therapy for glioblastoma: fact or fiction?Michael Weller, Roger Stupp, Monika Hegi, et al.Current Neurology and Neuroscience Reports|March 20, 2012
Clinical implications of molecular neuropathology and biomarkers for malignant gliomaGhazaleh Tabatabai, Monika Hegi, Roger Stupp, et al.Cell Death & Disease|April 21, 2017
Biological activity of tumor-treating fields in preclinical glioma modelsManuela Silginer, Michael Weller, Roger Stupp, et al.Current Treatment Options in Neurology|December 18, 2013
Treatment of primary CNS lymphomaPatrick Roth, Roger Stupp, Günter Eisele, et al.Current Pharmaceutical Design|August 11, 2011
The role of integrins in glioma biology and anti-glioma therapiesGhazaleh Tabatabai, Jorg-Christian Tonn, Roger Stupp, et al.Future Oncology (London, England)|October 6, 2010
Should biomarkers be used to design personalized medicine for the treatment of glioblastoma?Michael Weller, Wolfgang Wick, Monika E Hegi, et al.Neuro-Oncology|December 7, 2013
Levetiracetam and pregabalin for antiepileptic monotherapy in patients with primary brain tumors. A phase II randomized studyAndrea O Rossetti, Sandrine Jeckelmann, Jan Novy, et al.Pageof 103